LekoskopLekoskop
EN All changes
Medicine recalls and shortages › New approvals › 15 May 2026
MHRA approval

beremagene geperpavec (Vyjuvek)

Published on 15 May 2026 · source: MHRA — Medicines and Healthcare products Regulatory Agency
As with any medicine, the MHRA will keep the safety and effectiveness of Vyjuvek under close review.
MHRA announcement ↗ All events: beremagene geperpavec (Vyjuvek)

What this means

The MHRA has announced the approval of a medicine or a new indication in the UK. Approval does not mean the product is already available on the NHS: NICE appraisal and commissioning may follow.

Summary

As with any medicine, the MHRA will keep the safety and effectiveness of Vyjuvek under close review.

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.